<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Richardson CM</submitter><funding>NHLBI NIH HHS</funding><funding>NIDCD NIH HHS</funding><pagination>111371</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10243723</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>164</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Patients born with bilateral head and neck lymphatic malformations (BHNLMs) often require multiple invasive treatments, including tracheostomy. We hypothesized that primary targeted medical therapy (pTMT) with diagnostic needle aspiration reduces the need for invasive therapy such as surgical resection and/or sclerotherapy.&lt;h4>Methods&lt;/h4>Retrospective case review was performed of infants with BHNLMs (Grade 2 or De Serres stage IV and V) treated only at our institution from 2000 to 2021. Patients were divided into two cohorts: those managed with pTMT and those managed with observation, sclerotherapy, or surgical intervention (non-pTMT). Data regarding interventions, clinical outcomes, morbidity, and mortality were analyzed with descriptive statistics.&lt;h4>Results&lt;/h4>Nine</pubmed_abstract><journal>International journal of pediatric otorhinolaryngology</journal><pubmed_title>Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infants.</pubmed_title><pmcid>PMC10243723</pmcid><funding_grant_id>F32 HL147398</funding_grant_id><funding_grant_id>T32 DC000018</funding_grant_id><funding_grant_id>R01 HL130996</funding_grant_id><pubmed_authors>Richardson CM</pubmed_authors><pubmed_authors>Perkins JN</pubmed_authors><pubmed_authors>Bennett JT</pubmed_authors><pubmed_authors>Wenger TL</pubmed_authors><pubmed_authors>Bly RA</pubmed_authors><pubmed_authors>Jensen DM</pubmed_authors><pubmed_authors>Lutsky E</pubmed_authors><pubmed_authors>Zenner K</pubmed_authors><pubmed_authors>Dmyterko V</pubmed_authors><pubmed_authors>Perkins JA</pubmed_authors><pubmed_authors>Bull C</pubmed_authors><pubmed_authors>Bonilla-Velez J</pubmed_authors><pubmed_authors>Dahl JP</pubmed_authors><pubmed_authors>Geddis AE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infants.</name><description>&lt;h4>Objectives&lt;/h4>Patients born with bilateral head and neck lymphatic malformations (BHNLMs) often require multiple invasive treatments, including tracheostomy. We hypothesized that primary targeted medical therapy (pTMT) with diagnostic needle aspiration reduces the need for invasive therapy such as surgical resection and/or sclerotherapy.&lt;h4>Methods&lt;/h4>Retrospective case review was performed of infants with BHNLMs (Grade 2 or De Serres stage IV and V) treated only at our institution from 2000 to 2021. Patients were divided into two cohorts: those managed with pTMT and those managed with observation, sclerotherapy, or surgical intervention (non-pTMT). Data regarding interventions, clinical outcomes, morbidity, and mortality were analyzed with descriptive statistics.&lt;h4>Results&lt;/h4>Nine</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-06-01T01:18:16.764Z</modification><creation>2025-06-01T01:18:16.764Z</creation></dates><accession>S-EPMC10243723</accession><cross_references><pubmed>36459725</pubmed><doi>10.1016/j.ijporl.2022.111371</doi></cross_references></HashMap>